SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-22-046585
Filing Date
2022-02-18
Accepted
2022-02-18 16:03:40
Documents
2
Group Members
CHENG-HSIEN LINCHIN-NU LINCHIN-PEN LINGEORGE YEHKEELUNG HONGSEA CREST HOLDING CORP.TAI-PING WUTEAL SEA HOLDING CORP.TIEN-HUO CHENTLC BIOSCIENCES CORP.YAN-HUEI LINYU-HUA LIN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d97477dsc13da.htm SC 13D/A 214838
2 EX-99.1 d97477dex991.htm EX-99.1 10684
  Complete submission text file 0001193125-22-046585.txt   227196
Mailing Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503
Business Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503 886 2 2655 7377
Taiwan Liposome Company, Ltd. (Subject) CIK: 0001722890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F5 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90905 | Film No.: 22652632
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2F. NO. 3 YUANQU ST., NANGANG DIST. TAIPEI F5 105
Business Address
Lin Chang-Hai (Filed by) CIK: 0001813691 (see all company filings)

Type: SC 13D/A